Literature DB >> 8383385

Avian herpesvirus as a live viral vector for the expression of heterologous antigens.

P J Sondermeijer1, J A Claessens, P E Jenniskens, A P Mockett, R A Thijssen, M J Willemse, R W Morgan.   

Abstract

Control of Marek's disease in the poultry industry has been successfully achieved for several decades by large-scale vaccination of day-old chickens with live herpesvirus of turkeys (HVT) strains. Several features of this virus including lack of pathogenicity and long-term immune protection due to a persistent viraemic infection made us decide to use HVT as a live viral vector for the expression of foreign antigens. Potential sites for the integration of foreign DNA in the unique short region of the HVT genome were identified by the insertion of a beta-galactosidase expression cassette. Vaccination trials with recombinant virus strains indicated that the marker gene was expressed and stably maintained during animal passage. Based on an insertion site mapping in one of the open reading frames of the unique short region, a general recombination vector was designed for the integration of foreign genes into HVT. Recombinant virus-directed expression of individual antigens from Newcastle disease virus was driven by a strong promoter element derived from the lung terminal repeat sequence of Rous sarcoma virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383385     DOI: 10.1016/0264-410x(93)90198-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus.

Authors:  A S Anderson; M S Parcells; R W Morgan
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 3.  Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy.

Authors:  Rajamanonmani Ravikumar; Janlin Chan; Mookkan Prabakaran
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

4.  Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.

Authors:  Teshome Mebatsion; Marck J M Koolen; Leonie T C de Vaan; Niels de Haas; Marian Braber; Angela Römer-Oberdörfer; Paul van den Elzen; Pieter van der Marel
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene.

Authors:  M S Parcells; A S Anderson; R W Morgan
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

6.  Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames.

Authors:  M S Parcells; A S Anderson; J L Cantello; R W Morgan
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.

Authors:  M S Parcells; A S Anderson; T W Morgan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  A Recombinant Turkey Herpesvirus Expressing the F Protein of Newcastle Disease Virus Genotype XII Generated by NHEJ-CRISPR/Cas9 and Cre-LoxP Systems Confers Protection against Genotype XII Challenge in Chickens.

Authors:  Katherine Calderón; Aldo Rojas-Neyra; Brigith Carbajal-Lévano; Luis Luján-Valenzuela; Julio Ticona; Gisela Isasi-Rivas; Angela Montalvan; Manuel Criollo-Orozco; Edison Huaccachi-Gonzáles; Luis Tataje-Lavanda; Karla Lucia F Alvarez; Manolo Fernández-Sánchez; Manolo Fernández-Díaz; Na Tang; Yongxiu Yao; Venugopal Nair
Journal:  Viruses       Date:  2022-04-11       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.